recent publications

• academic article

  • Jiang, R., Frackowiak, B., Shin, Y. S., Song, X. Y., Chen, W. M., Lin, L., Cameron, M. D., Duckett, D. R., Kamenecka, T. M. Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors Bioorganic & Medicinal Chemistry Letters  2013 23:2683-2687  DOI:10.1016/j.bmcl.2013.02.082  PMID:23518277
  • Sessions, E. H., Smolinski, M., Wang, B., Frackowiak, B., Chowdhury, S., Yin, Y., Chen, Y. T., Ruiz, C., Lin, L., Pocas, J., Schroter, T., Cameron, M. D., et al. The development of benzimidazoles as selective Rho kinase inhibitors Bioorganic & Medicinal Chemistry Letters  2010 20:1939-1943  DOI:10.1016/j.bmcl.2010.01.124  PMID:20167489
  • Kamenecka, T., Habel, J., Duckett, D., Chen, W. M., Ling, Y. Y., Frackowiak, B., Jiang, R., Shin, Y. S., Song, X. Y., LoGrasso, P. Structure-activity relationships and X-ray structures describing the selectivity of aminopyrazole inhibitors for c-jun N-terminal kinase 3 (JNK3) over p38 Journal of Biological Chemistry  2009 284:12853-12861  DOI:10.1074/jbc.M809430200  PMID:19261605  PMCID:PMC2676016
  • Feng, Y. B., Cameron, M. D., Frackowiak, B., Griffin, E., Lin, L., Ruiz, C., Schroter, T., LoGrasso, P. Structure-activity relationships, and drug metabolism and pharmacokinetic properties for indazole piperazine and indazole piperidine inhibitors of ROCK-II Bioorganic & Medicinal Chemistry Letters  2007 17:2355-2360  DOI:10.1016/j.bmcl.2006.12.043  PMID:17368019